Quick Answer
Sunshine Biopharma Inc. reported Total Revenue of $34.87 million for fiscal year 2024.
Sunshine Biopharma Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $34.87M | +44.7% |
| 2023 | $24.09M | +454.4% |
| 2022 | $4.35M | +1802.4% |
| 2021 | $228.4K | +219.9% |
| 2020 | $71.4K | +238.1% |
| 2019 | $21.1K | — |
| 2018 | $0.00 | — |
| 2017 | $0.00 | — |
| 2016 | $0.00 | -100.0% |
| 2015 | $1.7K | — |
| 2014 | $0.00 | — |
| 2013 | $0.00 | — |
| 2012 | $0.00 | — |
| 2011 | $0.00 | — |
| 2010 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.42M | +11.6% | +0.1% |
| June 30, 2025 | $9.41M | +1.2% | +5.7% |
| March 31, 2025 | $8.90M | +18.0% | +5.5% |
| September 30, 2024 | $8.44M | +41.6% | -9.3% |
| June 30, 2024 | $9.30M | +67.3% | +23.4% |
| March 31, 2024 | $7.54M | +54.1% | +26.6% |
| September 30, 2023 | $5.96M | +4385.9% | +7.1% |
| June 30, 2023 | $5.56M | +3599.7% | +13.6% |
- Sunshine Biopharma Inc. showed an increase of +44.7% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Sunshine Biopharma Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 1, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: